<table id="id_8ff3bb0b-8254-492d-aa87-a13144edaf4e" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_9e0e9f62-9d70-4780-adce-672b60ac1995">Table 1: RELATIVE AND ABSOLUTE RISK SEEN IN THE CE/MPA SUBSTUDY OF WHI<footnote id="id-e9313b8c-5ca0-4ea8-91c9-a89115cf30d1">adapted from JAMA, 2002; 288:321-333<br/>
</footnote>
</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr id="id_50009fa5-b7fa-4bc0-a165-973ea3aa2053" stylecode="Toprule">
<td align="left" valign="top">Event <footnote id="id-e8345b18-4cce-4412-88e5-364b5428a6c5">a subset of the events was combined in a “global index”, defined as the earliest occurrence of CHD events, invasive breast cancer, stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip fracture, or death due to other causes<br/>
</footnote>
</td>
<td align="left" stylecode="Toprule" valign="top">
<paragraph>Relative Risk <br/>CE/MPA vs placebo<br/> at 5.2 Years</paragraph>(95% CI<footnote id="id-0c3e1ac2-7369-46cf-a89e-5855d286d038">nominal confidence intervals unadjusted for multiple looks and multiple comparisons</footnote>)</td>
<td align="left" stylecode="Toprule" valign="top">Placebo<br/>n = 8102</td>
<td align="left" valign="top">
<paragraph>CE/MPA</paragraph>n = 8506</td>
</tr>
<tr id="id_41c44bcd-c9e5-4a83-a632-953778e82902">
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" colspan="2" valign="top">
<paragraph>Absolute Risk per 10,000 Women-years</paragraph>
</td>
</tr>
<tr id="id_aed9fd50-4a27-4bac-88f5-848682c8c203">
<td align="left" valign="top">CHD events<br/>
<content stylecode="italics">Non-fatal MI<br/> CHD death</content>
</td>
<td align="center" valign="middle">1.29 (1.02 to 1.63)<br/>
<content stylecode="italics">1.32 (1.02 to 1.72)<br/>1.18 (0.70 to 1.97)</content>
</td>
<td align="center" valign="middle">30<br/>23<br/>6</td>
<td align="center" valign="middle">37<br/>
<content stylecode="italics">30<br/>7</content>
</td>
</tr>
<tr id="id_e04256dc-777d-49f2-89ab-609c4e7897dd">
<td align="left" valign="top">Invasive breast cancer<footnote id="id-e8ba978d-dd61-4d93-b03d-24d9b09cdc46">includes metastatic and non-metastatic breast cancer with the exception of in situ breast cancer<br/>
</footnote>
</td>
<td align="center" valign="middle">1.26 (1.00 to 1.59)</td>
<td align="center" valign="middle">30</td>
<td align="center" valign="middle">38</td>
</tr>
<tr id="id_2dc4a13d-9495-4c73-bd67-c1812e8c9e0c">
<td align="left" valign="top">Stroke</td>
<td align="center" valign="middle">1.41 (1.07 to 1.85)</td>
<td align="center" valign="middle">21</td>
<td align="center" valign="middle">29</td>
</tr>
<tr id="id_5d2d98fb-2787-4732-88b1-d3ee38f4646d">
<td align="left" valign="top">Pulmonary embolism</td>
<td align="center" valign="middle">2.13 (1.39 to 3.25)</td>
<td align="center" valign="middle">8</td>
<td align="center" valign="middle">16</td>
</tr>
<tr id="id_f929fab4-f844-4fd5-94cc-7c05cda75b07">
<td align="left" valign="top">Colorectal cancer</td>
<td align="center" valign="middle">0.63 (0.43 to 0.92)</td>
<td align="center" valign="middle">16</td>
<td align="center" valign="middle">10</td>
</tr>
<tr id="id_07b9f23b-65db-4c95-a939-66863d70605e">
<td align="left" valign="top">Endometrial cancer</td>
<td align="center" valign="middle">0.83 (0.47 to 1.47)</td>
<td align="center" valign="middle">6</td>
<td align="center" valign="middle">5</td>
</tr>
<tr id="id_bc5a1df3-c971-43de-a209-8670e54108e1">
<td align="left" valign="top">Hip fracture</td>
<td align="center" valign="middle">0.66 (0.45 to 0.98)</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">10</td>
</tr>
<tr id="id_ef48437f-cbb2-4677-b08b-3152e8b16ab1">
<td align="left" valign="top">Death due to causes other than the events above</td>
<td align="center" valign="middle">0.92 (0.74 to 1.14)</td>
<td align="center" valign="middle">40</td>
<td align="center" valign="middle">37</td>
</tr>
<tr id="id_c58963a7-cb7b-4eca-a4dd-5c34d70e7ad3">
<td align="left" valign="top">Global Index<footnoteref idref="id-e8345b18-4cce-4412-88e5-364b5428a6c5"></footnoteref>
</td>
<td align="center" valign="middle">1.15 (1.03 to 1.28)</td>
<td align="center" valign="middle">151</td>
<td align="center" valign="middle">170</td>
</tr>
<tr id="id_51383577-e4db-4b08-ba55-72108a0e3bdf">
<td align="left" valign="top">Deep vein thrombosis<footnote id="id-9db81cba-e6c4-4d4e-98b8-7e7980e01c95">not included in Global Index<br/>
</footnote>
</td>
<td align="center" valign="middle">2.07 (1.49 to 2.87)</td>
<td align="center" valign="middle">13</td>
<td align="center" valign="middle">26</td>
</tr>
<tr id="id_6e038968-ec23-46ab-b2f3-dad5cec8a496">
<td align="left" valign="top">Vertebral fractures<footnoteref idref="id-9db81cba-e6c4-4d4e-98b8-7e7980e01c95"></footnoteref>
</td>
<td align="center" valign="middle">0.66 (0.44 to 0.98)</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">9</td>
</tr>
<tr id="id_1d80063f-f596-428c-8be7-dce21a5fc333" stylecode="Botrule">
<td align="left" valign="top">Other osteoporotic fractures<footnoteref idref="id-9db81cba-e6c4-4d4e-98b8-7e7980e01c95"></footnoteref>
</td>
<td align="center" valign="middle">0.77 (0.69 to 0.86)</td>
<td align="center" valign="middle">170</td>
<td align="center" valign="middle">131</td>
</tr>
</tbody>
</table>